Physician profile
Rajesh Gupta
NPI 1477741197
$2,057.33
in general payments reported to CMS, 2019-2025
13 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $12.22 · 2023: $1,331 · 2024: $323 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,125 · Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,124.87 |
| Food and Beverage | $817.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,517.60 | 2023-2025 | Mitraclip, Triclip, Optis |
| Kestra Medical Technology Services, INC. | $122.60 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $104.02 | 2020-2025 | Cobenfy |
| Heartflow, INC. | $74.67 | 2024 | |
| Abiomed | $65.96 | 2019 | |
| Inari Medical, INC. | $51.03 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $36.41 | 2019 | |
| Biosense Webster, INC. | $31.28 | 2023 | Na |
| Terumo Medical Corporation | $21.42 | 2025 | Tr Band, Angio-Seal |
| Novo Nordisk INC | $18.32 | 2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $14.02 | 2024 | Farxiga |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.